UK markets close in 4 hours 56 minutes

Cambridge Cognition Holdings Plc (COG.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
51.75-0.25 (-0.48%)
As of 11:11AM BST. Market open.

Cambridge Cognition Holdings Plc

Tunbridge Court
Tunbridge Lane Bottisham
Cambridge CB25 9TU
United Kingdom
44 1223 810 700
https://www.cambridgecognition.com

Sector(s): Healthcare
Industry: Health Information Services
Full-time employees: 80

Key executives

NameTitlePayExercisedYear born
Dr. Matthew William StorkCEO & Director342kN/A1968
Mr. Stephen Daniel SymondsCFO & Executive Director203.31kN/A1975
Mr. John HammondCo-FounderN/AN/AN/A
Mr. Nick TaptiklisHead of Technology StrategyN/AN/AN/A
Ms. Francesca Cormack Ph.D.Chief Scientist & Member of Scientific Advisory BoardN/AN/AN/A
Mr. Simon MerrittMarketing and Communications DirectorN/AN/AN/A
Dr. Lisa Elizabeth Nolan Ph.D.Vice President Business DevelopmentN/AN/A1962
Ms. Nicky AckerleyGlobal HR DirectorN/AN/AN/A
Prof. Trevor Robbins CBE, FBPsS, FMedSci, FRS, Ph.D.Senior ConsultantN/AN/AN/A
Prof. Barbara Sahakian FBPsS, FMedSciSenior ConsultantN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency. It also provides CANTAB Connect Research, a proprietary platform that provides insights into behaviours, underlying brain circuits, and measurement of digital cognitive biomarkers; CANTAB Mobile, a touchscreen assessment of memory, mood, and functional status to detect the earliest signs of clinically relevant memory problems; CANTAB Insight to assess cognitive health; and CANTAB BrainHealth for assessing workplace wellbeing. In addition, the company offers electronic questionnaires and scales, a digital bespoke questionnaire; NeuroVocalix, a voice analysis platform to analyze voice to assess neurological change; cognition kit, a high frequency testing kit to detect changes over time and day-to-day cognition with short regular tests using patients' own devices. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.

Corporate governance

Cambridge Cognition Holdings Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.